EarliPoint Assessment— 510(k) K253442

Substantially Equivalent

Earlitec Diagnostics

FDA 510(k) clearance K253442 for EarliPoint Assessment, Substantially Equivalent on 2026-03-05. Applicant: Earlitec Diagnostics.

Clearance details

Applicant
Earlitec Diagnostics
Product code
Code QPF
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Plymouth, MN, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.